Document is current
Any future updates will be listed below
-
Authors
Siafis, Spyridon https://orcid.org/0000-0001-8264-2039
Çıray, Oğulcan
Wu, Hui
Schneider-Thoma, Johannes
Bighelli, Irene
Krause, Marc
Rodolico, Alessandro
Ceraso, Anna
Deste, Giacomo
Huhn, Maximilian
Fraguas, David
San José Cáceres, Antonia
Mavridis, Dimitris
Charman, Tony
Murphy, Declan G.
Parellada, Mara
Arango, Celso
Leucht, Stefan
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative (777394)
Ministerio de Ciencia, Innovación y Universidades
Instituto de Salud Carlos III (B2017/BMD-3740 AGES-CM-2)
Fundación Mutua Madrileña
Fundación Alicia Koplowitz
Fundación Familia Alonso
Horizon 2020 Framework Programme
- License Information
-
More Information
Article History
Received: 15 April 2021
Accepted: 2 February 2022
First Online: 4 March 2022
Declarations
:
: Not applicable.
: Not applicable.
: In the past 3 years Stefan Leucht has received honoraria as a consultant and/or advisor and/or for lectures from Alkermes, Angelini, Eisai, Gedeon Richter, Janssen, Lundbeck, Lundbeck Institute, Merck Sharpp and Dome, Otsuka, Recordati, Rovi, Sanofi Aventis, TEVA, Medichem, Mitshubishi. David Fraguas has been a consultant and/or has received fees from Angelini, Casen, Janssen, Lundbeck, and Otsuka. He has also received grant support from Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation) and from Fundación Alicia Koplowitz.Mara Parellada has received educational honoraria from Otsuka, research grants from FAK and Fundación Mutua Madrileña (FMM), Instituto de Salud Carlos III (Spanish Ministry of Science, Innovation and Universities) and European ERANET and H2020 calls, travel grants from Otsuka and Janssen. Consultant for Exeltis and Servier. Celso Arango has been a consultant to or has received honoraria or grants from Acadia, Angelini, Gedeon Richter, Janssen Cilag, Lundbeck, Otsuka, Roche, Sage, Sanofi, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion and Takeda. Maximilian Huhn has received speakers honoraria from Janssen. Declan Murphy has received consulting fees from Roche. Antonia San José Cáceres has been a consultant for Roche and is currently involved in clinical trials with Servier. The other authors have nothing to disclose.
